Progressive Care, Inc.
RXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $13,477 | $14,628 | $14,420 | $12,359 |
| % Growth | -7.9% | 1.4% | 16.7% | – |
| Cost of Goods Sold | $11,734 | $13,559 | $12,616 | $8,579 |
| Gross Profit | $1,743 | $1,069 | $1,804 | $3,781 |
| % Margin | 12.9% | 7.3% | 12.5% | 30.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,445 | $3,494 | $3,325 | $4,431 |
| SG&A Expenses | $1,250 | $3,494 | $1,207 | $4,431 |
| Sales & Mktg Exp. | $511 | $0 | -$2,117 | $0 |
| Other Operating Expenses | $0 | -$3,068 | $0 | $2,870 |
| Operating Expenses | $1,250 | $1,334 | $1,207 | $5,139 |
| Operating Income | $493 | -$265 | $596 | -$1,358 |
| % Margin | 3.7% | -1.8% | 4.1% | -11% |
| Other Income/Exp. Net | -$9,769 | -$107 | $27 | -$17 |
| Pre-Tax Income | -$9,276 | -$372 | -$13,273 | -$1,375 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,276 | -$372 | -$13,273 | -$1,375 |
| % Margin | -68.8% | -2.5% | -92% | -11.1% |
| EPS | -1.49 | -0.06 | -2.13 | -0.22 |
| % Growth | -2,400% | 97.2% | -868.2% | – |
| EPS Diluted | -1.49 | -0.06 | -2.13 | -0.22 |
| Weighted Avg Shares Out | 6,241 | 6,240 | 6,223 | 6,173 |
| Weighted Avg Shares Out Dil | 6,241 | 6,240 | 6,223 | 6,173 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40 | $40 | $42 | $22 |
| Interest Expense | $17 | $16 | $16 | $38 |
| Depreciation & Amortization | $786 | $820 | $818 | $747 |
| EBITDA | -$8,473 | $464 | -$14,574 | -$590 |
| % Margin | -62.9% | 3.2% | -101.1% | -4.8% |